Next |
home / stock / pran / pran message board
Subject | By | Source | When |
---|---|---|---|
What's going on? | HonTer | investorshub | 03/15/2019 3:45:22 PM |
come on u can squeeze, milly float | yankees18 | investorshub | 01/31/2019 2:56:56 PM |
Life Sciences out of Boston invested $32M earlier | crudeoil24 | investorshub | 01/31/2019 1:23:04 PM |
$PRAN NEWS http://pranabio.com/news/prana-receives-orphan-designation-for-pbt434- | TheFinalCD | investorshub | 01/31/2019 1:15:36 PM |
Conducting phase I > plus good news today | crudeoil24 | investorshub | 01/31/2019 12:50:14 PM |
took some | yankees18 | investorshub | 01/31/2019 12:22:33 PM |
$PRAN 1.90 33% up | ALERTS100%to10000%GAIN | investorshub | 01/31/2019 12:19:17 PM |
PRAN 1.42 in PM FDA NEWS Prana | ALERTS100%to10000%GAIN | investorshub | 01/31/2019 11:19:31 AM |
* * $PRAN Video Chart 01-02-19 * * | ClayTrader | investorshub | 01/02/2019 9:28:14 PM |
PRAN 2.36 on news , hit 3.29 earlier | TheFinalCD | investorshub | 01/02/2019 2:11:52 PM |
Last wk was a good one for $PRAN | rivervalley | investorshub | 07/07/2018 9:36:17 PM |
* * $PRAN Video Chart 07-05-18 * * | ClayTrader | investorshub | 07/05/2018 9:12:07 PM |
Bought back in this recently just over $2 | rivervalley | investorshub | 05/23/2018 9:45:23 PM |
No news...stock up good today....whats in store for tomorrow? | Stock player | investorshub | 10/20/2017 2:26:29 AM |
Monster VOLUME :-) | @LiftedCapital | investorshub | 10/19/2017 6:50:31 PM |
$PRAN buy 2.74 | stocktrademan | investorshub | 07/22/2017 5:37:11 PM |
* * $PRAN Video Chart 07-03-17 * * | ClayTrader | investorshub | 07/03/2017 6:23:33 PM |
Some stocks make no sense to me...in fact, | PositiveThoughts | investorshub | 06/03/2017 4:43:12 PM |
Today runner?? | Obelax | investorshub | 04/28/2017 1:17:15 PM |
Ideal short. Any pop is being added to | PLelek | investorshub | 03/31/2017 3:10:48 AM |
News, Short Squeeze, Breakout and More Instantly...
Prana Biotechnology Ltd Company Name:
PRAN Stock Symbol:
NASDAQ Market:
Prana Biotechnology Ltd (ASX: PBT, NASDAQ: PRAN) (“Prana” or “the Company”) has today announced the US Food and Drug Administration (FDA) has granted Orphan Drug designation for its lead molecule, PBT434, for the treatment of Multiple System Atrophy (MSA). This is...